Monday 22 February 2021

Neurodiagnostics Market Share | Industry Outlook Report to 2024

 The global Neurodiagnostics Market is anticipated to reach at USD 18.3 billion by 2024. Neurodiagnostics are also known as “Neurodiagnostic tests”. They diagnose neurological disorders such as migraine, Parkinson’s disease, stroke, ischemic stroke and epilepsy. The factors that propel the growth of the Neurodiagnostics Market include increasing occurrence of neurological disorders such as stroke, growing consciousness among people and technological developments. On the other hand, there are factors that may hamper the growth of the market including lack of mental health checkup & regular diagnosis in emerging countries. Neurodiagnostics industry is anticipated to grow at a significant CAGR in the upcoming period as the scope, product types, and its applications are increasing across the globe.

Request a Free Sample Copy of Neurodiagnostics Market Report @ https://www.millioninsights.com/industry-reports/neurodiagnostics-market/request-sample

The market may be explored by product type, end users, technology, and geography. The industry may be explored by product type as intracranial pressure monitor, Electromyography (EMG), Electroencephalogram (EEG), Transcranial Doppler, and Cerebral oximeters. The “Electroencephalogram (EEG)” segment led the Neurodiagnostics Market in 2015 and is anticipated to maintain its dominance by 2024.The key factor that could be attributed to the growth of market includes capacity to efficiently diagnoze epilepsy and the other neurological disorders through non-invasive methods.

Neurodiagnostics industry may be explored by technology as neuroimaging technologies that may further include Nuclear Medicine Imaging (SPECT, PET), Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Electroencephalography (EEG), Near Infrared Spectroscopic Imaging (NIRS), Voxel-based Morphometry (VBM), and Magnetoencephalography (MEG) in vitro diagnostics, and neuroinformatic.

The “CT and MRI” segment led the neurodiagnostics industry in 2015 and is anticipated to maintain its dominance by 2024.The factors that could be attributed to the growth of the segment might include increasing adoption in the internal body surgeries. The market could be explored based on end users as hospitals, operation theatres, neurophysiological

laboratories and clinics.
North America accounted for the major share of the Neurodiagnostics Market Size in 2015 and will continue to lead in the forecast period. The factors that could be attributed to the growth include increasing acceptance of neurodiagnostics technology.

For further inquiries, about - Global Neurodiagnostics Industry Analysis, Size, Growth, Trends and Forecast 2013 - 2024, click on this link – https://www.millioninsights.com/industry-reports/neurodiagnostics-market 

Some of the key players that fuel the growth of the neurodiagnostics industry comprise Alpha Omega Ltd., Bruker, Guerbet, Agilent Technologies, Fonar Corporation, Doric Lenses, Inc., GE Healthcare, Hitachi Medical Corporation, Hologic Inc., Mightex Systems, NeuroNexus Technologies, Neusoft Medical Systems Co., Ltd., Roche Diagnostics, Plexon, Inc., Philips Healthcare, Siemens Healthcare and Toshiba Medical Systems Corporation. The leading companies are taking up partnerships, mergers and acquisitions, and joint ventures in order to boost the inorganic growth of the industry.

Market Segment:

Technology Outlook (Market revenue in USD Million, 2013 - 2024)
• Neuroimaging Technologies
• Computed Tomography (CT)
• Magnetic Resonance Imaging (MRI)
• Nuclear Medicine Imaging (PET, SPECT)
• Near Infrared Spectroscopic Imaging (NIRS)
• Electroencephalography (EEG)
• Magnetoencephalography (MEG)
• Voxel-based Morphometry (VBM)
• In Vitro Diagnostics
• Neuroinformatics

Regional Outlook (Market Revenue in USD Million, 2013 - 2024)
• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• Japan
• China
• India
• Latin America
• Brazil
• Mexico
• Middle East and Africa
• South Africa

 

Varicose Vein Treatment Market Is Expected To Reach USD 475 Million By 2024

 Global Varicose Vein Treatment Market is anticipated to reach USD 475 million by 2024. Varicose veins literally known as “Veins on the leg”. They fall in the category of “varicose veins” if they get twisted. The factors that propel the growth of the Varicose Vein Treatment industry include reduced risk of collateral damage to adjacent tissues, painless technique, improved saturation, fewer post-operative complications, no requirement of anesthesia, less scarring, and minimal need for incisions during the procedure. On the other hand, there are factors that may hamper the growth of the market including shortage of trained vascular physicians and high price of varicose vein treatment methods.

Request a Free Sample Copy of Varicose Vein Treatment Market Report @ https://www.millioninsights.com/industry-reports/varicose-vein-treatment-market/request-sample 

Varicose Vein Treatment industry is anticipated to grow at a significant CAGR in the upcoming period as the scope, product types, and its applications are increasing across the globe. The market may be explored by treatment mode, product type, and geography. The industry may be explored by treatment mode as Surgical Ligation/Stripping, Endovenous Ablation, and Injection Sclerotherapy. The “Endovenous Ablation” sector led the Varicose Vein Treatment Market in 2016 and is anticipated to maintain its dominance by 2024.

The Varicose Vein Treatment industry could be explored based on product type as Venous Closure Products, Ablation Devices, Laser Ablation Devices, and Radiofrequency Ablation Devices. The “Radiofrequency Ablation Devices” sector led the Varicose Vein Treatment Market in 2016 and is anticipated to maintain its dominance by 2024.
North America accounted for the major share of the Varicose Vein Treatment Market Size in 2015 and will continue to lead in the forthcoming period. The factors that could be attributed to the growth include fast development in this market; which could be attributed to a number of aspects counting progressive health care infrastructure, high disposable income, increasing administration expenditure, continuous lifestyle-associated changes, rising health care consciousness, increasing occurrence of varicose veins, and rising consequence of esthetics.

Some of the key players that fuel the development of the Varicose Vein Treatment industry comprise AngioDynamics, Inc., Medtronic plc, Biolitec AG, Lumenis Ltd., Syneron Medical Ltd., Dornier MedTech GmbH, Energist Group, Quanta Systems S.p.A., Vascular Solutions, Inc., and Eufoton S.R.L. The leading companies are taking up partnerships, mergers and acquisitions, and joint ventures in order to boost the inorganic growth of the industry.

Download Full Research Report on “Varicose Vein Treatment Market” @ https://www.millioninsights.com/industry-reports/varicose-vein-treatment-market

Market Segment:

Varicose Vein Treatment Outlook ByType (Revenue, USD Million, 2013 - 2024)
• Sclerotherapy
• Endovenous Ablation
• Laser Ablation
• Radiofrequency Ablation
• Stripping

Varicose Vein Treatment Regional Outlook (Revenue, USD Million, 2013 - 2024)
• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Rest of Europe
• Asia Pacific
• India
• Japan
• China
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• MEA
• South Africa
• Rest of MEA

Contraceptives Market Analysis and Trends Report from 2012 to 2022

 The global Contraceptives Market is estimated to develop at a substantial CAGR for the duration of the prediction. The process of Contraception is thoughtful deterrence of pregnancy by way of interfering with standard procedure of ovulation, insemination, and imbedding by operating methods, medicines, blockades or medicinal devices. Contraceptives also avert gravidity and Sexually Transmitted Diseases [STDs].

The contraceptives industry is estimated to display substantial development for the duration of the prediction. This is credited to growing occurrence of sexually transmitted diseases, technical progressions in feminine contraceptive medications & apparatuses, growing inventiveness by NGOs and governments for the endorsement of contraceptives, and growing alertness among the public. On the other hand, the side effects linked with the usage of contraceptive apparatuses & medications, and increasing occurrence of sterility are controlling the progress of this market.

The Contraceptives market on the source of Type of Delivery Network could span Private Clinic, Self-governing Drug store, Communal, Online Display place, Private, Hospital’s Drugstore, and others. The Contraceptives on the source of Type of End Use could span Ambulatory Clinical Centers, Home-based Care, Private Clinic, Hospitals.

Request a Free Sample Copy of Contraceptives Market Report @ https://www.millioninsights.com/industry-reports/contraceptives-market-size/request-sample

The Contraceptives industry on the source of Type of Product could span Non-Surgical Permanent Contraception Devices, Intrauterine Devices, Contraceptive Sponges, Female Condoms, Male Contraceptive Devices, Topical Contraceptive Patch, Mini-pills, Oral Contraceptives, Sub-dermal Contraceptives Implants, Contraceptive Vaginal Rings, Contraceptive Diaphragms, Female Contraceptive Devices, Contraceptive Devices, Contraceptive Injectable, Combined Contraceptives, Contraceptive Drugs.

The Contraceptives market on the source of Area with respect to Trades in terms of intake, Profits, Market stake and Development percentage in these areas, for the duration of the prediction could span North America [U.S.A, Canada], Europe [France, Spain, Germany, U.K., Italy, Russia], Rest of Europe, Asia Pacific [India, Japan, China, Australia, and New Zealand], Rest of Asia Pacific, Latin America [Mexico, Brazil], Rest of Latin America, Middle East & Africa [GCC nations, South Africa], Rest of Middle East & Africa.

By the source of geography, North America was responsible for the mainstream of the stake of the international market during the past year. The contraceptives industry in North America is estimated to keep up its top position during the course of the prediction owing to growth in alertness among the inhabitants, increase in acceptance of fresh contraceptives, and growth in occurrence of sexually transmitted sicknesses for example HIV/AIDS. The contraceptive market in the U.S.A. books the biggest stake in the market of general contraceptives.

The Europe was an important area for the contraceptives during the past year. The development of this market is mostly owing to stress-free obtainability of contemporary contraceptives and recompense facility for extended period changeable contraceptive action. Asia-Pacific is projected to develop by the rapid step all through the prediction period, due to greater basis of inhabitant’s and active administrative organizations those concentrate on the control of birth.

Furthermore, technical progressions and economical contraceptive merchandises in these areas propose beneficial openings to the producers of contraceptives. Asia Pacific is estimated to be the maximum resourceful area in the contraceptive industry over the prediction period. Owing to robust financial development in the nations like Australia, Philippines, China, Singapore, India and others. The sanction of self-injection contraceptives by the controlling organization of the U.K., has presented it to the nations for example South Africa and additional nations having less earnings.

The report “Contraceptives Market Size & Forecast Report, 2012 - 2022” is available now at https://www.millioninsights.com/industry-reports/contraceptives-market-size 

The statement revises Trades in terms of intake of Contraceptives in the market; particularly in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. It concentrates on the topmost companies operating in these regions. Some of the important companies operating in the field on international level are Pfizer, Inc., Merck & Co., Inc., Cooper Surgical, Inc., Actavis, Inc., Medicines360, Medi safe Distribution Inc., Reckitt Benckiser plc, Mayer Laboratories, Inc., Church & Dwight, Co., Inc., Pace Pharmaceuticals Inc., Tewa Pharmaceutical Industries Limited, Bayer HealthCare AG.

Additional companies operating in the field on international level are Mithra Pharmaceuticals, Janssen Pharmaceutical Company, Allergan plc, Merck Co. Inc., Cipla Inc., HLL Life Care Limited, Mankind Pharma. Vardhman Life Care PVT. Ltd., Boehringer Ingelheim GmbH, TTK HealthCare, Agile Therapeutics Inc., Bio Santé Pharmaceuticals Inc., Mayer Laboratories, V-Care Pharma Pvt. Ltd., Watson Pharmaceuticals, Inc., Warner Chilcott Company.

Market Segment:

Global Contraceptives Product Outlook (Revenue, USD Million, 2012 - 2022)
• Contraceptive Drugs
• Contraceptive Pills
• Topical
• Injectables
• Contraceptive Devices
• Male Condoms
• Female Condoms
• Vaginal Implants
• Subdermal Implants
• Diaphragms
• Sponges
• IUDs
• Copper IUD
• Hormonal IUD

Contraceptives Regional Outlook (Revenue, USD Million, 2012 - 2022)
• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• Japan
• China
• India
• Rest of Asia Pacific
• Latin America
• Brazil
• Rest of Latin America
• Middle East and Africa
• South Africa
• Rest of Middle East and Africa

Wednesday 17 February 2021

Healthcare Cyber Security Market Will Rise Due To Technological Enhancements

 The global healthcare cyber security market is expected to cross USD 10.85 Million by 2022. Cybersecurity in healthcare is a mammoth task and for a large multispecialty, hospital with running practices and healthcare challenges today seem as a highly complex nature. The severity of the problem is the fact that every aspect of the challenge calls for accumulation of personal data, but no matter the size of cyber security in healthcare, attacks come as a surprise.

The healthcare cyber security market is driven by rise in precautionary measures against cyberattacks and cyber warfare. In addition, technological enhancements and increase in counterfeit accounts operating on a large scale are expected to contribute to the market growth in the near future. However, lack of spending on healthcare organizations and low awareness about potential cyber security levels is likely to hinder the market growth in the near future.

The healthcare cyber security is inclusive of segmentation by solution as identity and access management, risk and compliance management, security information, event management, intrusion detection system, antivirus, data encryption software and antivirus. Identity and access management accounts for a significant share in the market growth. End-user segmentation for healthcare cyber security market includes health insurance companies, pharmaceuticals & chemical industries and hospitals.

Geographical segmentation for healthcare cyber security market includes North America, Latin America, Europe, Asia-Pacific, Middle East and Africa. North America market accounts for a significant market share in the global scenario owing to enhanced technology, infrastructure, patient availability and rise in cyber security applications.

Asia-Pacific market accounts for a greater market share in the forecast period due to rise in cyber security applications, development of regulatory framework and rise in use of healthcare devices. The key players in the healthcare cyber security market include IBM, McAfee, Symantec, Fireye, Trend Micro Lockheed Martin, Northrop Grumma and Kaspersky.

Request a Free Sample Copy of Healthcare Cyber Security Market Report @ https://www.millioninsights.com/industry-reports/healthcare-cyber-security-market/request-sample

Market Segment:

Healthcare Cyber Security End-Use Outlook (Revenue, USD Million, 2012 - 2022)
• Pharmaceuticals & Chemicals
• Medical Devices
• Health Insurance
• Hospitals
• Others

Healthcare Cyber Security Type of Threat Outlook (Revenue, USD Million, 2012 - 2022)
• Pharmaceuticals & Chemicals
• Malware
• DDoS
• Advanced Persistent Threats (APT)
• Spyware
• Lost or Stolen Devices
• Others

Healthcare Cyber Security Type of Solution Outlook (Market Revenue in USD Million, 2012 - 2022)
• Identity and Access Management
• Risk and Compliance Management
• Antivirus and Antimalware
• DDoS Mitigation
• Security Information and Event Management (SIEM)
• Intrusion Detection System (IDS)/Intrusion Prevention System (IPS)
• Others

For further inquiries, about - Global Healthcare Cyber Security Industry Analysis, Size, Growth, Trends and Forecast 2012 - 2022, click on this link – https://www.millioninsights.com/industry-reports/healthcare-cyber-security-market

Healthcare Cyber Security Regional Outlook (Revenue, USD Million, 2012 - 2022)
• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• China
• Japan
• India
• Latin America
• Brazil
• Mexico
• MEA
• South Africa

Fitness Equipment Market Analysis and Trends Report 2012 - 2022

 The global fitness equipment market size is expected to value at USD 13.24 billion by 2022. The market is subject to witness a substantial growth due to the ever-growing urban population, increasing disposable income, particularly in the developing economies across the globe, and rising health consciousness among the general population. The fitness equipment is utilized to perform different types of exercises in regards to the physical wellbeing of the individual along with weight management, enhancing body stamina, and muscular strength of the individuals. Globally, the market is predicted to grow at CAGR of 3.6% in forecast period, providing numerous opportunities for market players to invest in research and development of the fitness equipment market.

Download Full Research Report on “Fitness Equipment Market” @ https://www.millioninsights.com/industry-reports/fitness-equipment-market

The fitness equipment that are increasingly used include treadmills, standing bicycles, abs & fitness twister, roller slide, cross trainer, and weightlifting machines. Factors responsible for robust market growth in the fitness equipment industry, in the recent years, include large number of obese population, rising health consciousness among general population, and increasing popularity of fitness equipment among younger population. Numerous initiatives undertaken by private and government authorities to promote corporate wellness programs are predicted to drive the growth of fitness equipment market in the upcoming years. However, high initial cost and increase in the resale activities of used devices are predicted to restrain market growth to a certain limit. Yet, soaring demand from developing economies across the globe are predicted to boost the demand for the fitness equipment over the forecast period.

Additionally, recent improvements and upgradation in the existing health security policies by local as well international authorities such as The United Nations (UN) and the World Health Organization (WHO) are expected to foster market in the near future. Increasing adoption of fitness equipment helps to prevent and monitor chronic diseases such as diabetes. Furthermore, increasing popularity of the fitness equipment in the developed economies is attributed to factors such as rising healthcare expenditure, and development of sports and nutrition programs and initiatives in order to encourage people belong to all ages, and backgrounds, thereby leading to active and healthy lifestyle.

This market is broadly categorized into three major types based on type of the device such as cardiovascular training, strength training, and body monitoring and analyzers. The strength training fitness equipment is considered as one of the fastest growing segment in the fitness equipment market with substantial revenue generation in the last couple of years. Growing popularity of the strength training fitness equipment segment kits is attributed to the growing demand form developing economies worldwide, rising young population and growing personal disposable incomes.

Request a Free Sample Copy of Fitness Equipment Market Report @ https://www.millioninsights.com/industry-reports/fitness-equipment-market/request-sample

Cardiovascular exercise market segment has also witnessed substantial growth owing to the increasing adoption on global scale coupled with rising commendation by physicians and healthcare professionals. Other factors playing major role in the rapid growth of the fitness equipment market, in the recent years include busy lifestyles and changing food patterns.

The market is divided by region as North America, Europe, Asia-Pacific, Latin America and Africa. North America has shown major growth in recent years owing to the rise in the implementation of latest technologies for manufacturing of the fitness equipment, growing large obese and overweight population, rising amount of government regulations in order to encourage and promote health awareness among the citizens, and existence of well-established market players in the region.

Asia-Pacific region is predicted to hold major market share in the fitness equipment market with massive growth in forecast period. Countries such as India, China, Japan and South Korea are leading the Asia-Pacific market with rising health consciousness among general population, increasing personal disposable income, and significant investment by leading industry players considering potential growth opportunities in the region.

The key players in the fitness equipment market are Amer Sports (Precor) Co., Brunswick Co., Cybex International Incorporations, Johnson Health Tech Co., Ltd., Nautilus Inc., Paramount Pvt., Ltd., Technogym Ltd., and Torque Fitness LLC.

Market Segment:

Fitness Equipment Device Outlook (Revenue, USD Million, 2012 - 2022)
• Cardiovascular training
• Strength training
• Others

Fitness Equipment End-Use Outlook (Revenue, USD Million, 2012 - 2022)
• Home
• Health clubs
• Others

Fitness Equipment Regional Outlook (Revenue, USD Million, 2012 - 2022)
• North America
• Europe
• Asia Pacific
• RoW

 

Tuesday 16 February 2021

Tourniquet Systems Market Will Grow At A CAGR Of 7.7% Over The Forecast Period

 Global Tourniquet Systems Market is expected to reach USD 594.8 million by 2025. Tourniquet Systems is a compressing device mainly used to control venous and arterial blood circulation to the lower or upper extremity for a period. Pressure is applied circumferentially on the skin and basic tissues of a limb. Further, this pressure is transported to the walls of vessels, causing them to become shortly choke. In surgical settings, the function of a Tourniquet is to apply adequate pressure on the arterial blood flow in a limb following exsanguinous to produce a comparatively bloodless operative field. The Tourniquet System Market is estimated to grow at a significant CAGR of 7.7% over the forecast period as the scope and its applications are rising enormously across the globe.

Request a Free Sample Copy of Tourniquet Systems Market Report @ https://www.millioninsights.com/industry-reports/tourniquet-systems-market/request-sample 

Growing geriatric population, increasing patient awareness regarding tourniquet system, and higher flexibility and consistency of tourniquet systems are documented as major factors of Tourniquet Systems Market that are estimated to enhance the growth in the years to come. However, high chances of disease caused by reusable cuffs and high hospital charges are the factors that may restrain overall market growth in the coming years. Tourniquet System Market is segmented based on product type, application, end user, and region.

Tourniquet cuffs and tourniquet instrument are the product types that could be explored in Tourniquet Systems in the forecast period. Tourniquet cuffs comprise non-pneumatic and pneumatic. Tourniquet cuffs sector accounted for the significant market share of Tourniquet System and is estimated to lead the overall market in the coming years, as rising awareness among customers and high demand in emergency, orthopedics, and trauma settings. In addition, pneumatic cuffs sector is estimated to grow at fastest pace with highest CAGR in the coming years.

The market may be categorized based on applications like leg cuffs, arm cuffs, and others that could be explored in the forecast period. Several end users like non-institutional, hospitals, physician/clinic, and others could be explored in Tourniquet Systems in the forecast period. Hospital sector accounted for the substantial market share of Tourniquet System and is estimated to continue its dominance in the coming years. Also, non-institutional sector is estimated to grow at fastest pace in the coming years.

Globally, North America accounted for the substantial market share of Tourniquet System and is estimated to lead the overall market in the coming years. The reason behind the overall market growth could be presence of developed and well-equipped healthcare infrastructure and presence of huge target population. The United States is a major consumer of Tourniquet Systems in the region.

The report “Tourniquet Systems Market” is available now at https://www.millioninsights.com/industry-reports/tourniquet-systems-market

Instead, Europe and the Asia Pacific are also estimated to have a positive influence on the future growth. Europe is the second largest region with significant market share. However, Asia Pacific is estimated to grow at fastest pace with the highest CAGR in the foremost period. The aspects that may be ascribed to the growth comprise rising number of road accidents, developing healthcare infrastructure, and growing population in the region. The developing countries like Indonesia, India, and Thailand are the major consumer of Tourniquet Systems in the region.

The key players of tourniquet systems industry are Rudolf Riester GmbH, Delfi Medical, Ulrich Medical, Zimmer Biomet, Stryker, Hammarplast Medical AB, and VBM Medizintechnik GmbH. These players are concentrating on inorganic growth to sustain themselves amongst fierce competition. As companies all over the world have to believe that alliance with a market would permit them proportional market existence and authority to declare the leadership position.

Market Segment:

Tourniquet Systems Component Outlook (Revenue, USD Million, 2014 - 2025)
• Tourniquet instrument
• Tourniquet cuffs
• Pneumatic
• Disposable
• Reusable
• Non-pneumatic

Tourniquet Systems Application Outlook (Revenue, USD Million, 2014 - 2025)
• Hospitals
• Ambulatory setting
• Non-institutional use

Tourniquet Systems Regional Outlook (Revenue, USD Million, 2014 - 2025)
• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• Asia Pacific
• China
• Japan
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• South Africa

To read more reports of this category, Visit our blog: https://healthandpharmamarketers.tumblr.com 

 

Thursday 11 February 2021

Bioresorbable Coronary Stents Market Is Predicted To Grow At CAGR Of 15% In Future

 The global Bioresorbable Coronary Stents Market size is expected to value at USD 247 million by 2025. The market is subject to witness a substantial growth due to the easy availability of post-approved with and tested lab results for Magmaris, Magnitude and next generation Absorb bioresorbable vascular scaffold (BVS) system.

Early adoption of the bioresorbable devices allows patients to live normal life with regular monitoring of artery. Bioresorbable devices also offers options to undergo an angioplasty in later stages in patient’s life. Globally, the bioresorbable coronary stents industry is predicted to grow at CAGR of 15% in forecast period, providing numerous opportunities for market players to invest for research and development in the market.

The pediatric patient suffering from genetic coronary conditions are targeted audience for fully dissolvable stents that enable normal functioning of vasomotor functions and vessel growth, thus driving the market demand for bioresorbable coronary stents market in recent years. Rising adoption of elective percutaneous coronary intervention or PCI techniques is one of the critical factors responsible for growth of the market.

Request a Free Sample Copy of Bioresorbable Coronary Stents Market Report @ https://www.millioninsights.com/industry-reports/bioresorbable-coronary-stents-market/request-sample

Increasing prevalence of cardiovascular diseases, stroke, coronary artery disease and atherosclerosis are giving rise to a growing number of concerns among healthcare professional and governmental agencies considering severity of these diseases. Changing food patterns, unhealthy lifestyles and obesity in urban areas across the globe are major risk factors leading to rise in incidence of stroke conditions, thus, driving the demand for interventional coronary procedures among young population.

Absence of primary guidelines to monitor procedure volumes and high approval rate by government agencies in various regions across the globe are anticipated to fuel the growth of the market. The Absorb bioresorbable vascular scaffold (BVS) is one of the fastest growing segment in the bioresorbable coronary stents industry with highest revenue generation in last couple of years. Though, unfavorable post-approval lab results are significantly hampering the sales of Absorb bioresorbable vascular scaffold (BVS) system due to concerns for safety and operational capability of such fully dissolvable devices. Thus, the rising need for more reliable and tested solutions coupled with post-approval data from governmental regulatory agencies, are opening up market for lesser known stents like Me Res-100 and DESolve in coming years.

Growing competition in the bioresorbable coronary stents market is expected boost market growth in upcoming years. Increasing number of joint ventures, acquisitions, and mergers by industry leaders for the development of the innovative products in the market are further solidifying market demand. Advent metallic bioresorbable device, termed as Magmaris that consists of metallic body, is capable of exerting higher radial force, compared to its counterparts in the market.

Numerous industry players are significantly investing for the development of advanced bioresorbable coronary stent such as second generation Absorb bioresorbable vascular scaffold (BVS) system to gain competitive edge in the market. Bioresorbable coronary stent is directly inserted into a blood vessel or other internal duct to completely avoid any blockage in the flow of the blood. Such critical advantages of the bioresorbable coronary stent are driving market growth in recent years.

For further inquiries, about - Global Bioresorbable Coronary Stents Industry Analysis, Size, Growth, Trends and Forecast 2016 - 2025, click on this link – https://www.millioninsights.com/industry-reports/bioresorbable-coronary-stents-market

The bioresorbable coronary stents industry is divided into regional market segment such as North America, Europe, Asia-Pacific, Latin America and Africa. European region has shown major growth in recent years owing to easy accessibility of CE-approved stents, and lack of presence for regular auditing checks, rise in the adoption of latest technologies, and existence well-established healthcare infrastructure.

Asia-Pacific region is predicted to hold major market share in the bioresorbable coronary stents market with massive growth in forecast period. Countries such as India, China and Japan are leading the Asia-Pacific market with rise in the patient pool and increasing investment by industry leaders considering potential opportunities in the region.

The key players in the bioresorbable coronary stents industry are BIOTRONIK Incorporations, Meril Lifesciences Private Limited., Elixir Medical Co., REVA Medical Incorporations, Arterial Remodeling Technologies S.A., Amaranth Medical Incorporations, Microport Scientific Co., and Arterius Limited.

Market Segment:

Bioresorbable Coronary Stents Brand Outlook (Revenue, USD Million; 2016 - 2025)
• Absorb BVS
• Absorb 2nd Generation
• Magmaris
• Magnitude
• MeRes-100
• DESolve

Bioresorbable Coronary Stents Regional Outlook (Revenue, USD Million; 2016 - 2025)
• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Asia Pacific
• Japan
• India

To read more reports of this category, Visit our blog: https://medicaldevicesmarketreports.tumblr.com 

Wednesday 10 February 2021

Cardiac Rehabilitation Market Forecast Report, 2014 - 2025

 The global Cardiac Rehabilitation Market size is expected to value at USD 2.52 billion by 2025. The market is subject to witness a substantial growth due to changing food patterns and increasing occurrence of cardiovascular diseases, obesity, and hyperlipidemia. With recent technological advancements in healthcare sector including tele-cardiac rehabilitation are some of the critical factors responsible for growth of the market. Tele-cardiac rehabilitation offers remote services from a distance with the help of information technology and telecommunications services. Other factors responsible for the sustained growth of the tele-cardiac rehabilitation market in recent years are numerous initiatives taken by local governments similar to the Million Hearts initiative and increase in the healthcare expenditure. Globally, the cardiac rehabilitation market is predicted to grow at CAGR of 6.3% in forecast period, providing numerous opportunity for market players to invest for research and development in the market.

The report “Cardiac Rehabilitation Market Size & Forecast Report, 2014 - 2025” is available now at https://www.millioninsights.com/industry-reports/cardiac-rehabilitation-market

Moreover, the rise in health awareness among individuals across the globe is propelling growth of market. Rise in new trends such as flexibility & mobility rollers and smart phone applications involving fitness and exercises are expected to boost demand for the cardiac rehabilitation market in coming years. Rise in health awareness and adoption of latest products for better endurance against diseases contributing to market expansion in past few years. Increase in healthcare expenditure by regional governments across the globe coupled with several supporting government interventions are positively influencing growth of the cardiac rehabilitation market in recent years. For example, initiatives taken by Centers for Medicare and Medicaid Services (CMS) are critical for prevention of heart disorders. As many as one million potential strokes and attacks has been prevented by such initiatives.

Changing lifestyle preferences and food patterns are major factors leading to diseases such as cardiovascular diseases, diabetes, and obesity thus contributing heavily to the growth of cardiac rehabilitation market global-scale. As per recent studies, diseases such as cardiovascular diseases and diabetes are leading cause of the death across the globe, thus significant focus has given for prevention and treatment associated with these diseases.
Cardiac rehabilitation allows adoption healthy lifestyle changes in order to avoid risk associated with cardiovascular disorders. Cardiac rehabilitation consists of various programs including various lifestyle changes such as healthy diet, regular counseling in order to release stress, and helping patient to live an active lifestyle. Cardiac rehabilitation enhances health and overall quality of life while limiting requirement for need for medication to treat heart related disorders. Cardiac rehabilitation reduces need to visit clinics by preventing potential future heart diseases, and increases overall life span of particular individual. Such factors are responsible for the growing demand of the cardiac rehabilitation in recent years.

Request a Free Sample Copy of Cardiac Rehabilitation Market Report @ https://www.millioninsights.com/industry-reports/cardiac-rehabilitation-market/request-sample

Cardiac rehabilitation is situated at an outpatient hospital or remotely located rehab center. Cardiac rehabilitation team consists of healthcare professionals, nurses, fitness specialists, physicians, dietitians, and mental health specialists. Cardiac rehabilitation performs various tests such as an electrocardiogram (EKG), cardiac and imaging tests coupled with regular exercises as prescribed by fitness specialists. Frequent testing of cholesterol and blood sugar levels of a patient helps to monitor performance and remain physically active during entire period of cardiac rehabilitation.

The cardiac rehabilitation market is divided into regional market segment such as North America, Europe, Asia-Pacific, Latin America and Africa. North America has shown major growth in recent years owing to the rise in the adoption of latest technologies and existence of well-established healthcare infrastructure. Asia-Pacific region is predicted to hold major market with massive growth in forecast period. Countries such as India, China and Singapore are leading the Asia-Pacific market with rise in geriatric population and increase in the awareness about health and fitness among individuals.

The key players in the cardiac rehabilitation market are Ball Dynamics, Inc., Honeywell Incorporations, Core Health & Fitness LLC, LifeWatch Incorporations, Philips N.V., Amer Sports Co., Smiths Group Plc, Omron Co., Halma Plc, and Brunswick Co.

Market Segment:

Product (Revenue, USD Million, 2014 - 2025)
• Ellipticals
• Stabilization ball
• Stationary ball
• Treadmill
• Heart rate monitor
• Blood pressure monitor
• Rovers
• Others

To read more reports of this category, Visit our blog: https://healthandpharamceuticalmarket.blogspot.com 

Regional Outlook (Revenue, USD Million, 2014 - 2025)
• North America
• U.S
• Canada
• Europe
• UK
• Germany
• Italy
• Spain
• France
• Asia Pacific
• Japan
• China
• India
• Latin America
• Brazil
• Mexico
• Middle East and Africa (MEA)
• South Africa
• Saudi Arabia